JV

Jitendra Venilal Dave

Active Director Director DIN 02992946
DIN 02992946 First appointment Apr 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2010
Shareholding value •••• Premium profile

About Jitendra Venilal Dave

Data last updated:

Jitendra Venilal Dave is a Director at Stl Pharma Private Limited (since 2010). The company operates in Healthcare. Stl Pharma Private Limited reported revenue of ₹73.55 Cr (FY 2024).

DIN 02992946
Primary Designation Director
Industry Healthcare
First Appointment 12 Apr 2010
Oldest Company Age 16 yrs
Largest company Stl Pharma Private Limited · ₹73.55 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stl Pharma Private Limited U24100MH2010PTC201926
Director12 Apr 20102010₹73.55 Cr (FY 2024)Active

Board colleagues of Jitendra Venilal Dave

Directorship timeline

Open interactive timeline →
Stl Pharma Private Limited
Premium access

Shareholding and investment profile for Jitendra Venilal Dave

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jitendra Venilal Dave

Jitendra Venilal Dave currently holds 1 directorship: Stl Pharma Private Limited (Director, since 12 Apr 2010, revenue ₹73.55 Cr (FY 2024)).

Jitendra Venilal Dave was first appointed on 12 Apr 2010 as Director at Stl Pharma Private Limited.

The current boards of Jitendra Venilal Dave's companies include Sejal Viral Dave (Stl Pharma Private Limited), Viral Jitendra Dave (Stl Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available